Generic placeholder image

Current Bioactive Compounds

Author(s): Deepika Joshi* and Priya Sharma

DOI: 10.2174/1573407219666230420114706

DownloadDownload PDF Flyer Cite As
A Comprehensive Review on Herbal Nanoparticulate System through Intranasal Route for Management of Congenital-Neuro Zika Therapy

Article ID: e200423216143 Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Background: An arbovirus called the Zika virus is spread by Aedes mosquitoes. The Zika virus (ZIKV) epidemic that has recently spread over the Western Hemisphere (the Americas and the ongoing outbreak in Brazil) is now recognised as one of the main causes of neurologic disease and other potential neurologic consequences.

Methods: There are currently no antivirals available, and vaccines are only available for some. Currently, only symptomatic treatment is available. Various herbal plants, vegetables, fruits, flowers, and microbes have been documented to exhibit antiviral activities possessing good tolerability and minimal side effects. Polyphenols and other phyto-constituents have been extensively studied against arboviruses and have demonstrated promising results.

Results: This review article focuses on a potential new herbal formulation with strong antiviral properties against the current zika virus and accompanying symptoms, with intranasal administration as the preferred method for treating neurological symptoms.

Conclusion: Natural anti-viral therapy plays an important role in contributing to antiviral drug development and in reducing the global infection burden of arboviruses.

Graphical Abstract

[1]
Kuno, G.; Chang, G.J.J. Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch. Virol., 2007, 152(4), 687-696.
[http://dx.doi.org/10.1007/s00705-006-0903-z] [PMID: 17195954]
[2]
Kumar, S.; Verma, A.; Yadav, P.; Dubey, S.K.; Azhar, E.I.; Maitra, S.S.; Dwivedi, V.D. Molecular pathogenesis of Japanese encephalitis and possible therapeutic strategies. Arch. Virol., 2022, 167(9), 1739-1762.
[http://dx.doi.org/10.1007/s00705-022-05481-z] [PMID: 35654913]
[3]
Chambers, T.J.; Hahn, C.S.; Galler, R.; Rice, C.M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol., 1990, 44(1), 649-688.
[http://dx.doi.org/10.1146/annurev.mi.44.100190.003245] [PMID: 2174669]
[4]
Sharma, D.; Akhter, H.B. Global emergence of aedes arboviral diseases: Management and treatment. Inventi Rapid: Infect. Dis. Immunol., 2019, 2019(2), 1-11.
[5]
Baud, D.; Gubler, D.J.; Schaub, B.; Lanteri, M.C.; Musso, D. An update on Zika virus infection. Lancet, 2017, 390(10107), 2099-2109.
[http://dx.doi.org/10.1016/S0140-6736(17)31450-2] [PMID: 28647173]
[6]
Ferraris, P.; Cochet, M.; Hamel, R.; Gladwyn-Ng, I.; Alfano, C.; Diop, F.; Garcia, D.; Talignani, L.; Montero-Menei, C.N.; Nougairède, A.; Yssel, H.; Nguyen, L.; Coulpier, M.; Missé, D. Zika virus differentially infects human neural progenitor cells according to their state of differentiation and dysregulates neurogenesis through the Notch pathway. Emerg. Microbes Infect., 2019, 8(1), 1003-1016.
[http://dx.doi.org/10.1080/22221751.2019.1637283] [PMID: 31282298]
[7]
Foy, B.D.; Kobylinski, K.C.; Foy, J.L.C.; Blitvich, B.J.; Travassos da Rosa, A.; Haddow, A.D.; Lanciotti, R.S.; Tesh, R.B. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg. Infect. Dis., 2011, 17(5), 880-882.
[http://dx.doi.org/10.3201/eid1705.101939] [PMID: 21529401]
[8]
Brencic, D.J.; Pinto, M.; Gill, A.; Kinzer, M.H.; Hernandez, L.; Pasi, O.G. CDC support for global public health emergency management. Emerg. Infect. Dis., 2017, 23(13), S183-S189.
[http://dx.doi.org/10.3201/eid2313.170542] [PMID: 29155652]
[9]
Hills, S.L.; Fischer, M.; Petersen, L.R. Epidemiology of Zika Virus infection. J. Infect. Dis., 2017, 216(S10), S868-S874.
[http://dx.doi.org/10.1093/infdis/jix434] [PMID: 29267914]
[10]
Krauer, F.; Riesen, M.; Reveiz, L.; Oladapo, O.T.; Martínez-Vega, R.; Porgo, T.V.; Haefliger, A.; Broutet, N.J.; Low, N. Zika virus infection as a cause of congenital brain abnormalities and guillain–barré syndrome: Systematic review. PLoS Med., 2017, 14(1)e1002203
[http://dx.doi.org/10.1371/journal.pmed.1002203] [PMID: 28045901]
[11]
Dick, G.W.A.; Kitchen, S.F.; Haddow, A.J. Zika Virus (I). isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg., 1952, 46(5), 509-520.
[http://dx.doi.org/10.1016/0035-9203(52)90042-4] [PMID: 12995440]
[12]
Bradley, M.P.; Nagamine, C.M. Animal models of zika virus. Comp. Med., 2017, 67(3), 242-252.
[PMID: 28662753]
[13]
Erdő, F.; Bors, L.A.; Farkas, D.; Bajza, Á.; Gizurarson, S. Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res. Bull., 2018, 143, 155-170.
[http://dx.doi.org/10.1016/j.brainresbull.2018.10.009] [PMID: 30449731]
[14]
Retallack, H.; Di Lullo, E.; Arias, C.; Knopp, K.A.; Laurie, M.T.; Sandoval-Espinosa, C.; Mancia Leon, W.R.; Krencik, R.; Ullian, E.M.; Spatazza, J.; Pollen, A.A.; Mandel-Brehm, C.; Nowakowski, T.J.; Kriegstein, A.R.; DeRisi, J.L. Zika virus cell tropism in the developing human brain and inhibition by azithromycin. Proc. Natl. Acad. Sci., 2016, 113(50), 14408-14413.
[http://dx.doi.org/10.1073/pnas.1618029113] [PMID: 27911847]
[15]
Meertens, L.; Labeau, A.; Dejarnac, O.; Cipriani, S.; Sinigaglia, L.; Bonnet-Madin, L.; Le Charpentier, T.; Hafirassou, M.L.; Zamborlini, A.; Cao-Lormeau, V.M.; Coulpier, M.; Missé, D.; Jouvenet, N.; Tabibiazar, R.; Gressens, P.; Schwartz, O.; Amara, A. Axl mediates ZIKA virus entry in human glial cells and modulates innate immune responses. Cell Rep., 2017, 18(2), 324-333.
[http://dx.doi.org/10.1016/j.celrep.2016.12.045] [PMID: 28076778]
[16]
Tricarico, P.M.; Caracciolo, I.; Crovella, S.; D’Agaro, P. Zika virus induces inflammasome activation in the glial cell line U87-MG. Biochem. Biophys. Res. Commun., 2017, 492(4), 597-602.
[http://dx.doi.org/10.1016/j.bbrc.2017.01.158] [PMID: 28153732]
[17]
Cugola, F.R.; Fernandes, I.R.; Russo, F.B.; Freitas, B.C.; Dias, J.L.M.; Guimarães, K.P.; Benazzato, C.; Almeida, N.; Pignatari, G.C.; Romero, S.; Polonio, C.M.; Cunha, I.; Freitas, C.L.; Brandão, W.N.; Rossato, C.; Andrade, D.G.; Faria, D.P.; Garcez, A.T.; Buchpigel, C.A.; Braconi, C.T.; Mendes, E.; Sall, A.A.; Zanotto, P.M.A.; Peron, J.P.S.; Muotri, A.R.; Beltrão-Braga, P.C.B. The Brazilian Zika virus strain causes birth defects in experimental models. Nature, 2016, 534(7606), 267-271.
[http://dx.doi.org/10.1038/nature18296] [PMID: 27279226]
[18]
Dang, J.; Tiwari, S.K.; Lichinchi, G.; Qin, Y.; Patil, V.S.; Eroshkin, A.M.; Rana, T.M. Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3. Cell Stem Cell, 2016, 19(2), 258-265.
[http://dx.doi.org/10.1016/j.stem.2016.04.014] [PMID: 27162029]
[19]
Calvet, G.; Aguiar, R.S.; Melo, A.S.O.; Sampaio, S.A.; de Filippis, I.; Fabri, A.; Araujo, E.S.M.; de Sequeira, P.C.; de Mendonça, M.C.L.; de Oliveira, L.; Tschoeke, D.A.; Schrago, C.G.; Thompson, F.L.; Brasil, P.; dos Santos, F.B.; Nogueira, R.M.R.; Tanuri, A.; de Filippis, A.M.B. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: A case study. Lancet Infect. Dis., 2016, 16(6), 653-660.
[http://dx.doi.org/10.1016/S1473-3099(16)00095-5] [PMID: 26897108]
[20]
Garcez, P.P.; Loiola, E.C.; Madeiro da Costa, R.; Higa, L.M.; Trindade, P.; Delvecchio, R.; Nascimento, J.M.; Brindeiro, R.; Tanuri, A.; Rehen, S.K. Zika virus impairs growth in human neurospheres and brain organoids. Science, 2016, 352(6287), 816-818.
[http://dx.doi.org/10.1126/science.aaf6116] [PMID: 27064148]
[21]
Centers for Disease Control and Prevention (CDC). Outcomes of pregnancies with laboratory evidence of possible Zika virus infection in the United States, 2016.
[22]
Smith, D.E.; Beckham, J.D.; Tyler, K.L.; Pastula, D.M. Zika virus disease for neurologists. Neurol. Clin. Pract., 2016, 6(6), 515-522.
[http://dx.doi.org/10.1212/CPJ.0000000000000307] [PMID: 28058206]
[23]
Petersen, E.; Wilson, M.E.; Touch, S.; McCloskey, B.; Mwaba, P.; Bates, M.; Dar, O.; Mattes, F.; Kidd, M.; Ippolito, G.; Azhar, E.I.; Zumla, A. Rapid spread of zika virus in the Americas-implications for public health preparedness for mass gatherings at the 2016 brazil olympic games. Int. J. Infect. Dis., 2016, 44, 11-15.
[http://dx.doi.org/10.1016/j.ijid.2016.02.001] [PMID: 26854199]
[24]
Wen, Z.; Song, H.; Ming, G. How does Zika virus cause microcephaly? Genes Dev., 2017, 31(9), 849-861.
[http://dx.doi.org/10.1101/gad.298216.117] [PMID: 28566536]
[25]
Barjas-Castro, M.L.; Angerami, R.N.; Cunha, M.S.; Suzuki, A.; Nogueira, J.S.; Rocco, I.M.; Maeda, A.Y.; Vasami, F.G.S.; Katz, G.; Boin, I.F.S.F.; Stucchi, R.S.B.; Resende, M.R.; Esposito, D.L.A.; de Souza, R.P.; da Fonseca, B.A.; Addas-Carvalho, M. Probable transfusion-transmitted Zika virus in Brazil. Transfusion, 2016, 56(7), 1684-1688.
[http://dx.doi.org/10.1111/trf.13681] [PMID: 27329551]
[26]
Wongsurawat, T.; Athipanyasilp, N.; Jenjaroenpun, P.; Jun, S.R.; Kaewnapan, B.; Wassenaar, T.M.; Leelahakorn, N.; Angkasekwinai, N.; Kantakamalakul, W.; Ussery, D.W.; Sutthent, R.; Nookaew, I.; Horthongkham, N. Case of microcephaly after congenital infection with Asian lineage Zika Virus, Thailand. Emerg. Infect. Dis., 2018, 24(9), 1758-1761.
[http://dx.doi.org/10.3201/eid2409.180416] [PMID: 29985788]
[27]
McGrogan, A.; Madle, G.C.; Seaman, H.E.; de Vries, C.S. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology, 2009, 32(2), 150-163.
[http://dx.doi.org/10.1159/000184748] [PMID: 19088488]
[28]
Cao-Lormeau, V.M.; Blake, A.; Mons, S.; Lastère, S.; Roche, C.; Vanhomwegen, J.; Dub, T.; Baudouin, L.; Teissier, A.; Larre, P.; Vial, A.L.; Decam, C.; Choumet, V.; Halstead, S.K.; Willison, H.J.; Musset, L.; Manuguerra, J.C.; Despres, P.; Fournier, E.; Mallet, H.P.; Musso, D.; Fontanet, A.; Neil, J.; Ghawché, F. Guillain-barré syndrome outbreak associated with Zika virus infection in french polynesia: A case-control study. Lancet, 2016, 387(10027), 1531-1539.
[http://dx.doi.org/10.1016/S0140-6736(16)00562-6] [PMID: 26948433]
[29]
Wang, L.; Valderramos, S.G.; Wu, A.; Ouyang, S.; Li, C.; Brasil, P.; Bonaldo, M.; Coates, T.; Nielsen-Saines, K.; Jiang, T.; Aliyari, R.; Cheng, G. From mosquitos to humans: Genetic evolution of Zika virus. Cell Host Microbe, 2016, 19(5), 561-565.
[http://dx.doi.org/10.1016/j.chom.2016.04.006] [PMID: 27091703]
[30]
Ioos, S.; Mallet, H.P.; Leparc Goffart, I.; Gauthier, V.; Cardoso, T.; Herida, M. Current Zika virus epidemiology and recent epidemics. Med. Mal. Infect., 2014, 44(7), 302-307.
[http://dx.doi.org/10.1016/j.medmal.2014.04.008] [PMID: 25001879]
[31]
de Paula Freitas, B.; de Oliveira Dias, J.R.; Prazeres, J.; Sacramento, G.A.; Ko, A.I.; Maia, M.; Belfort, R., Jr Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in Salvador, Brazil. JAMA Ophthalmol., 2016, 134(5), 529-535.
[http://dx.doi.org/10.1001/jamaophthalmol.2016.0267] [PMID: 26865554]
[32]
Batista, M.; Braga, A.; Campos, G.; Souza, M.; Matos, R.; Lopes, T.; Candido, N.; Lima, M.; Machado, F.; Andrade, S.; Bittar, C.; Nogueira, M.; Carneiro, B.; Mariutti, R.; Arni, R.; Calmon, M.; Rahal, P. Natural products isolated from oriental medicinal herbs inactivate Zika virus. Viruses, 2019, 11(1), 49.
[http://dx.doi.org/10.3390/v11010049] [PMID: 30641880]
[33]
Cirne Santos, C.C.; Barros, C.D.S.; Paixao, I.C.N. Natural products against the zika virus. Am. J. Biomed., 2020, 7(3), 221-223.
[http://dx.doi.org/10.34297/AJBSR.2020.07.001146]
[34]
Wakerley, B.R.; Yuki, N. Isolated facial diplegia in Guillain-Barré syndrome: Bifacial weakness with paresthesias. Muscle Nerve, 2015, 52(6), 927-932.
[http://dx.doi.org/10.1002/mus.24887] [PMID: 26315943]
[35]
Susuki, K.; Koga, M.; Hirata, K.; Isogai, E.; Yuki, N. A guillain-barré syndrome variant with prominent facial diplegia. J. Neurol., 2009, 256(11), 1899-1905.
[http://dx.doi.org/10.1007/s00415-009-5254-8] [PMID: 19633904]
[36]
Kassavetis, P.; Joseph, J.M.B.; Francois, R.; Perloff, M.D.; Berkowitz, A.L. Zika virus–associated Guillain-Barré syndrome variant in Haiti. Neurology, 2016, 87(3), 336-337.
[http://dx.doi.org/10.1212/WNL.0000000000002759] [PMID: 27164708]
[37]
Rozé, B.; Najioullah, F.; Signate, A.; Apetse, K.; Brouste, Y.; Gourgoudou, S.; Fagour, L.; Abel, S.; Hochedez, P.; Cesaire, R.; Cabié, A. Zika virus detection in cerebrospinal fluid from two patients with encephalopathy, Martinique, February 2016. Euro Surveill., 2016, 21(16)
[http://dx.doi.org/10.2807/1560-7917.ES.2016.21.16.30205] [PMID: 27123558]
[38]
Carteaux, G.; Maquart, M.; Bedet, A.; Contou, D.; Brugières, P.; Fourati, S.; Cleret de Langavant, L.; de Broucker, T.; Brun-Buisson, C.; Leparc-Goffart, I.; Mekontso Dessap, A. Zika virus associated with meningoencephalitis. N. Engl. J. Med., 2016, 374(16), 1595-1596.
[http://dx.doi.org/10.1056/NEJMc1602964] [PMID: 26958738]
[39]
Schwartzmann, P.V.; Ramalho, L.N.Z.; Neder, L.; Vilar, F.C.; Ayub-Ferreira, S.M.; Romeiro, M.F.; Takayanagui, O.M.; dos Santos, A.C.; Schmidt, A.; Figueiredo, L.T.M.; Arena, R.; Simões, M.V. Zika virus meningoencephalitis in an immunocompromised patient. Mayo Clin. Proc., 2017, 92(3), 460-466.
[http://dx.doi.org/10.1016/j.mayocp.2016.12.019] [PMID: 28259231]
[40]
Duca, L.M.; Beckham, J.D.; Tyler, K.L.; Pastula, D.M. Zika virus disease and associated neurologic complications. Curr. Infect. Dis. Rep., 2017, 19(1), 4.
[http://dx.doi.org/10.1007/s11908-017-0557-x] [PMID: 28220392]
[41]
Man, A.; Santacroce, L.; Iacob, R.; Mare, A.; Man, L. Antimicrobial activity of six essential oils against a group of human pathogens: A comparative study. Pathogens, 2019, 8(1), 15.
[http://dx.doi.org/10.3390/pathogens8010015] [PMID: 30696051]
[42]
Govindarajan, M.; Kadaikunnan, S.; Alharbi, N.S.; Benelli, G. Single-step biological fabrication of colloidal silver nanoparticles using Hugonia mystax: Larvicidal potential against Zika virus, dengue, and malaria vector mosquitoes. Artif. Cells Nanomed. Biotechnol., 2017, 45(7), 1317-1325.
[http://dx.doi.org/10.1080/21691401.2016.1228664] [PMID: 27611658]
[43]
Mishra, A.; Shaik, H.A.; Sinha, R.K.; Shah, B.R. Andrographolide: A herbal-chemosynthetic approach for enhancing immunity, combating viral infections, and its implication on human health. Molecules, 2021, 26(22), 7036.
[http://dx.doi.org/10.3390/molecules26227036] [PMID: 34834128]
[44]
Welch, J.L.; Xiang, J.; Okeoma, C.M.; Schlievert, P.M.; Stapleton, J.T. Glycerol monolaurate, an analogue to a factor secreted by lactobacillus, is virucidal against enveloped viruses, including HIV-1. MBio, 2020, 11(3), e00686-e20.
[http://dx.doi.org/10.1128/mBio.00686-20] [PMID: 32371599]
[45]
Mounce, B.C.; Cesaro, T.; Carrau, L.; Vallet, T.; Vignuzzi, M. Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. Antiviral Res., 2017, 142, 148-157.
[http://dx.doi.org/10.1016/j.antiviral.2017.03.014] [PMID: 28343845]
[46]
Singh, N.A.; Kumar, P.; Jyoti, S.; Kumar, N. Spices and herbs: Potential antiviral preventives and immunity boosters during COVID ‐19. Phytother. Res., 2021, 35(5), 2745-2757.
[http://dx.doi.org/10.1002/ptr.7019] [PMID: 33511704]
[47]
Gonzalez, M.J.; Berdiel, M.J.; Miranda-Massari, J.R.; Duconge, J.; Rodríguez-López, J.L.; Adrover-López, P.A. High dose intravenous vitamin C treatment for zika fever. J. Orthomol. Med., 2016, 31(1), 19-22.
[PMID: 36177383]
[48]
Kaushik, S.; Jangra, G.; Kundu, V.; Yadav, J.P.; Kaushik, S. Anti-viral activity of Zingiber officinale (Ginger) ingredients against the Chikungunya virus. Virusdisease, 2020, 31(3), 270-276.
[http://dx.doi.org/10.1007/s13337-020-00584-0] [PMID: 32420412]
[49]
Saxena, S.K.; Elahi, A.; Gadugu, S.; Prasad, A.K. Zika virus outbreak: An overview of the experimental therapeutics and treatment. Virusdisease, 2016, 27(2), 111-115.
[http://dx.doi.org/10.1007/s13337-016-0307-y] [PMID: 27366760]
[50]
Lan, X.; Wang, W.; Li, Q.; Wang, J. The natural flavonoid pinocembrin: Molecular targets and potential therapeutic applications. Mol. Neurobiol., 2016, 53(3), 1794-1801.
[http://dx.doi.org/10.1007/s12035-015-9125-2] [PMID: 25744566]
[51]
Shen, X.; Liu, Y.; Luo, X.; Yang, Z. Advances in biosynthesis, pharmacology, and pharmacokinetics of pinocembrin, a promising natural small-molecule Drug. Molecules, 2019, 24(12), 2323.
[http://dx.doi.org/10.3390/molecules24122323] [PMID: 31238565]
[52]
Yang, Z.H.; Sun, X.; Qi, Y.; Mei, C.; Sun, X.B.; Du, G.H. Uptake characteristics of pinocembrin and its effect on p-glycoprotein at the blood–brain barrier in in vitro cell experiments. J. Asian Nat. Prod. Res., 2012, 14(1), 14-21.
[http://dx.doi.org/10.1080/10286020.2011.620393] [PMID: 22263589]
[53]
Lee, J.L.; Loe, M.W.C.; Lee, R.C.H.; Chu, J.J.H. Antiviral activity of pinocembrin against Zika virus replication. Antiviral Res., 2019, 167, 13-24.
[http://dx.doi.org/10.1016/j.antiviral.2019.04.003] [PMID: 30959074]
[54]
Federico, A.; Dallio, M.; Loguercio, C. Silymarin/silybin and chronic liver disease: A marriage of many years. Molecules, 2017, 22(2), 191.
[http://dx.doi.org/10.3390/molecules22020191] [PMID: 28125040]
[55]
Dunnick, J.K.; Singh, B.; Nyska, A.; Peckham, J.; Kissling, G.E.; Sanders, J.M. Investigating the potential for toxicity from long-term use of the herbal products, goldenseal and milk thistle. Toxicol. Pathol., 2011, 39(2), 398-409.
[http://dx.doi.org/10.1177/0192623310394211] [PMID: 21300790]
[56]
Saller, R.; Brignoli, R.; Melzer, J.; Meier, R. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch. Komplement. Med., 2008, 15(1), 9-20.
[http://dx.doi.org/10.1159/000113648] [PMID: 18334810]
[57]
Clain, E.; Haddad, J.G.; Koishi, A.C.; Sinigaglia, L.; Rachidi, W.; Desprès, P.; Duarte dos Santos, C.N.; Guiraud, P.; Jouvenet, N.; El Kalamouni, C. The polyphenol-rich extract from Psiloxylon mauritianum, an endemic medicinal plant from reunion island, inhibits the early stages of dengue and Zika virus infection. Int. J. Mol. Sci., 2019, 20(8), 1860.
[http://dx.doi.org/10.3390/ijms20081860] [PMID: 30991717]